WO2011044176A1 - Devices, systems and methods for treatment of neuropsychiatric disorders - Google Patents
Devices, systems and methods for treatment of neuropsychiatric disorders Download PDFInfo
- Publication number
- WO2011044176A1 WO2011044176A1 PCT/US2010/051542 US2010051542W WO2011044176A1 WO 2011044176 A1 WO2011044176 A1 WO 2011044176A1 US 2010051542 W US2010051542 W US 2010051542W WO 2011044176 A1 WO2011044176 A1 WO 2011044176A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nerve
- electrode
- patient
- cutaneous
- branch
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0476—Array electrodes (including any electrode arrangement with more than one electrode for at least one of the polarities)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0472—Structure-related aspects
- A61N1/0492—Patch electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0504—Subcutaneous electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0529—Electrodes for brain stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36053—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for vagal stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36057—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for stimulating afferent nerves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36064—Epilepsy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36067—Movement disorders, e.g. tremor or Parkinson disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36071—Pain
- A61N1/36075—Headache or migraine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36082—Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36082—Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
- A61N1/36096—Mood disorders, e.g. depression, anxiety or panic disorder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/3615—Intensity
- A61N1/3616—Voltage density or current density
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36167—Timing, e.g. stimulation onset
- A61N1/36171—Frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36146—Control systems specified by the stimulation parameters
- A61N1/36167—Timing, e.g. stimulation onset
- A61N1/36175—Pulse width or duty cycle
Definitions
- the present disclosure generally relates to cutaneous neuromodulation devices and systems and methods of using the same. More specifically, methods, devices, and systems configured for the treatment of neuropsychiatric disorders, such as mood, cognitive and behavioral disorders, via trigeminal nerve stimulation ("TNS") are provided. Devices and systems configured for stimulation of superficial sensory branches of cranial nerves and their methods of application are described.
- TNS trigeminal nerve stimulation
- Psychiatric or neuropsychiatric disorders for example depressive disorders
- DD sometimes referred to as depression, or anxiety disorders
- ECT electroconvulsive therapy
- VNS vagus nerve stimulation
- DBS Food and Drug Administration
- One aspect of the subject matter of the present disclosure addresses the aforementioned needs by providing a method of treating psychiatric disorders and systems and devices configured to stimulate the ophthalmic (supraorbital), infraorbital and mentalis branch(es) of the trigeminal nerve, and more specifically by providing a method of treating psychiatric disorders using trigeminal nerve stimulation (TNS).
- TMS trigeminal nerve stimulation
- an electrode assembly configured for the cutaneous stimulation of the trigeminal nerve.
- a method of treating psychiatric disorders using the disclosed electrode assembly is provided.
- a method of treating a psychiatric disorder in a patient the method
- a method of treating a psychiatric disorder in a patient comprising: providing an electrode assembly provided in accordance with claim 2; attaching the electrode assembly to the patient so as to contact the skin surface over at least one of the ophthalmic or supraorbital nerve; and applying electric signals to the electrode assembly at a frequency between 20 and 300 Hertz, at a pulse duration between 50 and 250 microseconds, at an output current density of not greater than 25 niA/cm 2 and an output charge density of not greater than 10 ⁇ / ⁇ 2 at the cerebral cortex.
- a system for trigeminal nerve stimulation for treatment of a neuropsychiatric disorder includes: a pulse generator and a cutaneous electrode assembly.
- the cutaneous electrode assembly includes a first electrode comprising at least one contact configured for cutaneous placement at a first region of the patient's face, wherein the first electrode is configured to contact a portion of the patient's face overlying the cutaneous distribution of at least one branch of the trigeminal nerve, wherein the system is configured for minimal current penetration into a brain of a patient, and wherein the at least one branch of the trigeminal nerve is selected from the group consisting of: ophthalmic nerve, infraorbital nerve, mentalis nerve, supratrochlear nerve, infratrochlear nerve, zygomaticotemporal nerve, zygomaticofacial nerve,
- the system may further include a second electrode comprising at least one contact configured for cutaneous placement at a second region of the patient's face, wherein the second electrode is configured to contact a portion of the patient's face overlying the cutaneous distribution of at least one branch of the trigeminal nerve, wherein the at least one branch of the trigeminal nerve is selected from the group consisting of: ophthalmic nerve, infraorbital nerve, mentalis nerve, supratrochlear nerve, infratrochlear nerve, zygomaticotemporal nerve,
- the first electrode and the second electrode are configured to contact a portion of the patient's face overlying the cutaneous distribution of a same branch of the trigeminal nerve. In some embodiments, the first electrode and the second electrode are configured to contact a portion of the patient's face overlying the cutaneous distribution of a different branch of the trigeminal nerve.
- the system may further include a wire operably connecting the pulse generator and the cutaneous electrode assembly.
- the system may further include a regulating device configured to regulate the maximum charge balanced output current below approximately 30-50 mA.
- cutaneous electrode assembly for trigeminal nerve stimulation for treatment of a neuropsychiatric disorder.
- the assembly includes: a first electrode comprising at least one contact configured for cutaneous placement at a first region of the patient's face, wherein the first electrode is configured to contact a portion of the patient's face overlying the cutaneous distribution of at least one branch of the trigeminal nerve, wherein the assembly is configured for minimal current penetration into a brain of a patient, and wherein the at least one branch of the trigeminal nerve is selected from the group consisting of: ophthalmic nerve, infraorbital nerve, mentalis nerve, supratrochlear nerve, infratrochlear nerve, zygomaticotemporal nerve, zygomaticofacial nerve, zygomaticoorbital nerve, nasal nerve, and auriculotemporal nerve.
- the assembly may further include a second electrode comprising at least one contact configured for cutaneous placement at a second region of the patient's face, wherein the second electrode is configured to contact a portion of the patient's face overlying the cutaneous distribution of at least one branch of the trigeminal nerve, wherein the at least one branch of the trigeminal nerve is selected from the group consisting of: ophthalmic nerve, infraorbital nerve, mentalis nerve, supratrochlear nerve, infratrochlear nerve,
- the first electrode and the second electrode are configured to contact a portion of the patient's face overlying the cutaneous distribution of a same branch of the trigeminal nerve. In one embodiment, the first electrode and the second electrode are configured to contact a portion of the patient's face overlying the cutaneous distribution of a different branch of the trigeminal nerve. In one embodiment, the
- neuropsychiatric disorder is selected from the group consisting of: mood disorder, cognitive disorder, behavioral disorder and anxiety disorder.
- a method for treating a neuropsychiatric disorder by trigeminal nerve stimulation includes contacting a first region of a patient's face with a cutaneous electrode assembly, the cutaneous electrode assembly comprising: a first electrode comprising at least one contact configured for cutaneous placement at a first region of the patient's face, wherein the first electrode is configured to contact a portion of the patient's face overlying the cutaneous distribution of at least one branch of the trigeminal nerve, wherein the assembly is configured for minimal current penetration into a brain of a patient, and wherein the at least one branch of the trigeminal nerve is selected from the group consisting of: ophthalmic nerve, infraorbital nerve, mentalis nerve, supratrochlear nerve, infratrochlear nerve,
- zygomaticotemporal nerve zygomaticofacial nerve, zygomaticoorbital nerve, nasal nerve, and auriculotemporal nerve; and applying electrical signals to the electrode assembly at specified operational parameters to treat a neuropsychiatric disorder.
- the electrode assembly may further include a second electrode comprising at least one contact configured for cutaneous placement at a second region of the patient's face, wherein the second electrode is configured to contact a portion of the patient's face overlying the cutaneous distribution of at least one branch of the trigeminal nerve, wherein the at least one branch of the trigeminal nerve is selected from the group consisting of: ophthalmic nerve, infraorbital nerve, mentalis nerve, supratrochlear nerve, infratrochlear nerve, zygomaticotemporal nerve, zygomaticofacial nerve, zygomaticoorbital nerve, nasal nerve, and auriculotemporal nerve.
- the step of applying electrical signals comprises applying electrical signals at a frequency between approximately 20 and 300 Hertz, at a current of 0.05 to 5 milliamperes (mA) and at a pulse duration of less than or equal to 500 microseconds. In one embodiment, the step of applying electrical signals comprises applying electrical signals at a frequency between approximately 20 and 300 Hertz, at a pulse duration between approximately 50 and 500 microseconds, at an output current density of not greater than approximately 25 mA/cm 2 and an output charge density of not greater than approximately 10 microCoulomb/cm 2 at the cerebral cortex.
- the neuropsychiatric disorder is selected from the group consisting of: mood disorder, cognitive disorder, behavioral disorder and anxiety disorder.
- kits for trigeminal nerve stimulation for treatment of a neuropsychiatric disorder includes: the cutaneous electrode assembly as described herein; and instructions for placing the electrode assembly on a patient for treatment of a neuropsychiatric disorder.
- the kit may include a pulse generator; and instructions for applying electrical signals to the electrode assembly for treatment of a neuropsychiatric disorder.
- Figs. 1A and IB illustrate the location of several branches (nerves) of the trigeminal nerve and the location of the major foramina for the superficial branches of the trigeminal nerve;
- FIG. 2 shows an embodiment of a system including an electrode assembly provided according to aspects of the present disclosure
- FIG. 3A depicts an enlarged view of the electrode assembly of Fig. 2;
- Fig. 3B depicts representative dimensions of the electrode assembly of Fig.
- Fig. 6A is a table showing an average of the results of four assessment tests pre-treatment and post treatment of a treatment study for psychiatric disorders using aspects of the present disclosure
- Fig. 6B is a bar graph of the data shown in Fig. 6A;
- Fig. 6C is a graph illustrating the change over time of the data shown in Fig.
- Fig. 7 summarizes one embodiment of current, charge, current density and charge density parameters for a subject exposed to cutaneous stimulation of the supraorbital nerve.
- the present disclosure relates to methods, devices and systems used for the treatment of mood, anxiety, post traumatic stress disorder, and cognitive and behavioral disorders (collectively, neuropsychiatric disorders) via stimulation of the superficial elements of the trigeminal nerve ("TNS"). More specifically, cutaneous methods of stimulation of the superficial branches of the trigeminal nerve located extracranially in the face, namely the supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticotemporal,
- zygomaticoorbital, zygomaticofacial, infratrochlear, nasal and mentalis nerves are disclosed herein.
- Methods for the treatment of mood and other neuropsychiatric disorders by eTNS external trigeminal nerve stimulation
- systems and devices configured for therapeutic stimulation of the trigeminal nerve or branches thereof, such as the superficial trigeminal nerve, and their methods of application are also described.
- Some brain stimulation methods aim to generate currents in large volumes of the cortex and treat the brain as a bulk conductor, for example, ECT (electroconvulsive therapy) at the whole-lobe level and rTMS (repetitive transcranial magnetic stimulation) at the large regional level (i.e. dorsolateral prefrontal cortex).
- ECT electrocatalyzesive therapy
- rTMS repetitive transcranial magnetic stimulation
- deep brain stimulation is generally predicated on stimulation of small but regional volumes that lead to discharges in a very large number of cells.
- the systems, devices and methods of the present disclosure send minimal, if any, current into the brain; instead, signals are sent into the brain in order to modify the activity of relevant neuroanatomical structures.
- the electrical pulses generate signals in the cutaneous branches of the trigeminal nerve and the electric fields are generally confined to the skin tissue and there is minimal, if any, leakage into the brain. These electrical pulses trigger a cascade of change in neuronal signaling events that involve very limited and precise recruitment of specific networks of neurons.
- the neuroanatomic pathways allow targeted modulation of activity in areas involved in depression (locus coeruleus, anterior cingulate, insula, amygdala, and other cortical and subcortical structures).
- the systems, devices and methods as disclosed herein utilize the brain's existing infrastructure to transmit signals to the targets of interest.
- minimal current penetration means (1) a charge density of approximately 0 uC/cm 2 at the cerebral cortex, or (2) calculated, measured, or modeled charge densities below the following thresholds at the cerebral cortex: (a) at currents, charge densities, or charge per phase not likely to cause direct activation of pyramidal neurons and axons; and (b) to prevent brain injury, a charge density of less than lOuC/cm 2 in one embodiment, and, in other embodiments, a charge density of less than 1.0 uC/cm 2 and in some embodiments, a charge density of less than 0.001 to 0.1 uC/cm 2 , and at combinations of charge density and charge per phase not known to cause brain injury.
- a lower charge density may be used when the central nervous system of an individual patient is sufficiently sensitive to lower levels of stimulation that the lower level will still permit clinical benefit to accrue.
- VPM ventral posterior medial nucleus
- Light touch sensory fibers are large myelinated fibers, which ascend to the ventral posterior lateral (VPL) nucleus of the thalamus. Afferent sensory fibers project from the trigeminal nuclei to the thalamus and the cerebral cortex.
- the trigeminal nucleus has reciprocal projections to the nucleus tractus solitarius (NTS), the locus coeruleus, the cerebral cortex and the vagus nerve.
- NTS receives afferents from the vagus nerve and trigeminal nerve.
- NTS integrates input from multiple sources, and projects to structures in the brainstem and forebrain, including the locus coeruleus.
- the locus coeruleus is a paired nuclear structure in the dorsal pons, and is located just beneath the floor of the fourth ventricle.
- the locus coeruleus has extensive axonal projections to a broad number of brainstem, sub-cortical and cortical structures, and is an important part of the reticular activating system.
- the locus coeruleus is a core part of the brainstem noradrenergic pathway, and produces the neurotransmitter norepinephrine.
- Norepinephrine plays a key role in attention, alertness, blood pressure and heart rate regulation, and mood.
- connections between the trigeminal nerve and the locus coeruleus, thalamus, amygdala, anterior cingulate, and other central nervous system structures as described above may be relevant to a potential role of the trigeminal nerve in
- neuropsychiatric disorders including mood (such as depression), anxiety (such as posttraumatic stress disorder) and other cognitive and behavioral disorders.
- mood such as depression
- anxiety such as posttraumatic stress disorder
- other cognitive and behavioral disorders including cognitive and behavioral disorders.
- FIG. 2A-5 show various embodiments of the systems and devices that may be used for the cutaneous stimulation of the superficial branches of the trigeminal nerve and methods of using the same.
- the electrode assembly is configured for unilateral stimulation.
- the electrode assembly is configured for bilateral stimulation.
- bilateral stimulation may offer similar or better efficacy than unilateral stimulation because the function of different brain structures may not be the same on right and left (e.g.
- neuropsychiatric disorders comprises positioning external electrodes over a plurality of foramina and simultaneously stimulating different trigeminal nerves.
- electrodes may be positioned at a region of the patient's face (on the right and/or left side) corresponding with the supratrochlear nerve, infratrochlear nerve, zygomaticotemporal, zygomaticofacial, zygomaticoorbital, nasal, and/or auriculotemporal nerves and/or their respective foramina.
- the electrodes connect to leads for conveying the electrical stimuli from a neurostimulator.
- the neurostimulation may be provided using an electrical neurostimulator at the following exemplary settings: frequency 20-150 Hz, current 1-10 niA, pulse duration (pulse width) of 50-250 microseconds, a duty cycle of 10% to 50%, for at least one hour per day.
- stimulation parameters at the lower end of these ranges may be used.
- different values of the operational parameters may be used.
- a single external electrode can be used.
- a portable external stimulator which can be attached to a patient's clothing, is used.
- a system 200 for treatment of neuropsychiatric disorders via TNS includes an electrode assembly 100, electrical cable or wire 120 and an external neurostimulator or pulse generator 122.
- the pulse generator may be an internal pulse generator.
- the electrode assembly may be configured for the bilateral simultaneous and asynchronous stimulation of the ophthalmic nerves.
- the neurostimulator or pulse generator may be any type of appropriate stimulating, signal-generating device.
- the generator 122 is portable and attached to the belt of a patient 20. However, either a portable or non-portable pulse generator may be used. As shown in Fig.
- the electrode assembly 100 is connectable to an external stimulator 122 either by lead wires 124 connected to an electrical cable 120 or wirelessly. That is, in one embodiment, the electrical cable or wire 120 is configured to provide a physical and electrical link between the generator 122 and the electrode assembly 100 via lead wires 124. In other embodiments, the generator 122 and the electrode assembly 100 communicate wirelessly (i.e. the wire 120 and leads 124 are not used).
- the system 200 or elements thereof, such as the electrode assembly 100 may be part of a kit.
- the kit may also include instructions for placement of the electrode system and/or system.
- the kit may also include instructions for treatment of a neuropsychiatric disorder according to a method as disclosed herein.
- the system 200 may also include a regulation device to ensure safe use of the system.
- the regulation device is configured to be attached to the pulse generator 122 and is configured to govern the maximum charge balanced output current below approximately 30-50mA to minimize current penetration to the brain and increase patient tolerance.
- the regulation device may be internally programmed to range from 0.25- 5.0 mA, 0 - 10mA, 0-15mA, depending on the surface area, placement, and orientation of the electrode, and whether the electrode is stimulating near or adjacent to the skull, or away from the skull, (mentalis), where current ranges may be higher or lower.
- Current TENS units stimulate with maximum output currents of up to 100 mA's, which result in currents which may penetrate the skull and which may not be well tolerated.
- the electrode assembly 100 further includes a retainer element 130 configured to secure the electrode assembly to a patient's forehead.
- the retainer element 130 can be an elastic band or strap.
- the electrode assembly 100 can be secured in place by a hat or a cap which also serves to conceal the electrode assembly from view.
- the electrode assembly may be secured by adhesive, such as an adhesive strip, an adhesive backing surrounding the conducting area or an adhesive conductive gel.
- the electrode assembly comprises an electrode with at least one contact.
- a single electrode may have a plurality of contacts.
- the electrode assembly comprises pair of electrodes with a pair of contacts.
- the electrode assembly may be a strip electrode with at least one contact.
- the strip electrode may include a plurality of contacts.
- the electrode assembly 100 shown in Figs. 2-3B is also referred to as a bilateral supraorbital electrode.
- the electrode assembly 100 includes a first pair of contacts 112a, 112b for placement on a first region of the patient's face, and a second pair of contacts 1 14a, 1 14b for placement on a second region of the patient's face.
- the first region is the right side of the patient's face and the second region is the left side of the patient's face.
- the first pair of contacts comprises a first upper contact 112a and a first lower contact 1 12b
- the second pair of contacts comprises a second upper contact 114a and a second lower contact 114b.
- the first and second contact pairs are connected to each other by an insulative connection region 1 16.
- the electrode assembly 100 comprises an inner contact surface 1 18 that comes into contact with a patient's skin at four contact areas, each corresponding to one of the four contacts 112a, 1 12b, 114a, 114b.
- the inner contact surface 118 comprising the four contact areas includes a buffered gel-like adhesive that provides good electrical conductivity with minimum skin irritation, an example of such gel includes the commercially available hydrogels from AmGel Technologies (AmGel Technologies, Fallbrook, CA, USA).
- the electrode assembly 100 is configured to stimulate both the right and left ophthalmic nerves either simultaneously or asynchronously.
- the insulative connection region 1 16 serves to assist a patient in lining up the electrode assembly 100 with the midline of the nose to ensure proper placement of the electrode assembly 100 over both ophthalmic nerves, which lie on the average about 2.1 to 2.6 cm from the nasal midline of an adult patient.
- the electrode assembly can be placed accurately (e.g. by the patient) without knowledge of the location of the ophthalmic nerve or key landmarks relative to the nerve, thereby reducing the possibility of inadequate stimulation due to errors in positioning of the electrodes.
- this configuration of the electrode assembly 100 allows the contact pairs 1 12a/l 12b and 1 14a/l 14b to be stimulated independently and/or unilaterally, as the response to stimulus may be localized and thus varied from one side of the midline to the other side. That is, the presently disclosed electrode assembly permits individual adjustment of current for the first and second regions or right and left sides, as applicable, thereby reducing asymmetric stimulation and/or perceived asymmetric stimulation.
- FIGS. 4A-4C illustrate other embodiments of the electrode assembly 100, which configurations may be used to stimulate the right and/or left ophthalmic nerve and/or other branches of the trigeminal nerve as disclosed herein, such as the zygomaticofacial and/or the auriculotemporal nerves.
- the bilateral supraorbital electrode is specially configured for bilateral supraorbital stimulation. It is scalable based on the location of use, stimulation parameters and input from computer modeling so as to negate or minimize or render safe, current penetration into the brain. As skin irritation may occur, a similar configuration could be applied unilaterally, so as to provide relief to one side of the forehead, to promote skin tolerability and to reduce the risk of irritation. Other configurations of size and inter electrode distance can be conceived for different branches of the trigeminal nerve, as shown in Figs. 4A-4C.
- a strip electrode with at least two contacts may be used to stimulate the auriculotemporal and/or zygomaticofacial nerve.
- two separate electrodes may be used to stimulate the auriculotemporal and/or zygomaticofacial nerve.
- the upper contacts 112a, 114a and lower contacts 112b, 1 14 have fixed polarities.
- the upper contacts 1 12a, 1 14a and lower contacts 1 12b, 114b have alternating polarities.
- the inferior electrode typically serves as the cathode for the leading phase of the stimulating pulse. In the case of a monophasic stimulation, the inferior electrode generally becomes the cathode.
- 1 14b is sized to deliver an electrical pulse over a large enough surface area to minimize any skin injury due to excess current density and/or charge density, and to minimize or eliminate current penetration beyond the inner surface of the skull bone.
- the distance between the first contact pair 112a, 1 12b and the second contact pair 114a, 1 14b is configured to stimulate the ophthalmic nerves while minimizing or eliminating current delivery to the surface of the brain.
- the mid-point of each of the contacts is approximately 2.5 cm (range 1.5 cm to 3.5 cm) from the nasal midline.
- the electrode size and the inter-electrode distance may vary for children and adults, males and females based on anatomical differences.
- the electrode is approximately 32.5mm in length by 12.5mm in height and the inter-electrode distance between, for example, the upper pair of electrodes 1 12a, 1 14a is 17.5 mm and the inter-electrode distance between, for example, the upper electrode 112a and the lower electrode 1 12b is 20mm.
- the length of the electrode may be greater than or less than 32.5mm and greater than or less than 12.5 mm in height.
- the inter electrode distance can be in a range greater than 20mm and/or less than 17.5mm.
- the surface area of each of the contacts 1 12a, 1 12b, 114a, and 1 14b can be within a range of about 0.5 cm 2 to about 20 cm 2 .
- the distance between the contacts 1 12a and 1 12b and the distance between contacts 1 14a, and 114b can be in a range of about 0.5 cm to about 10 cm. Those of skill in the art will recognize that one or more of the above distances can be used as a border of a range of distances.
- FIG. 5 illustrates another embodiment of the electrode assembly 100. As shown in Fig. 5, a patient 10 is wearing two separate electrodes 12 on the forehead, one over each eyebrow, corresponding to the foramina of the ophthalmic nerves.
- one embodiment of the present device comprises a unilateral electrode assembly configured for the unilateral stimulation of ophthalmic nerves.
- the instant electrode assembly can also be configured for the stimulation of the maxillary nerves or the mandibular nerves.
- an electrode assembly configured for the simultaneous stimulation of a plurality of trigeminal nerve branches is also within the scope of the present disclosure.
- the system or electrode assembly as disclosed herein may be configured to stimulate the auriculotemporal nerve.
- the system or electrode assembly as disclosed herein may be configured to stimulate the zygomaticofacial nerve.
- the electrode assembly 100 is positioned over the forehead of the patient 20 such that the insulative connection region 1 16 lines up with the midline of the patient's nose. In some embodiments, the electrode assembly 100 is placed over the supraorbital foramina, located over the orbital ridge approximately 2.1-2.6 cm lateral to nasal midline. The electrode assembly 100 may then be connected to the external neurostimulator 122 via lead wires 124 and the electrical cable 120. In other embodiments, the electrode assembly 100 is connected to the neurostimulator 122 via a wireless connection. Stimulation according to patient specific operational parameters as determined according to the methods described herein is then applied.
- the method of treating psychiatric disorders comprises positioning the electrode assembly 100 to the forehead of a patient, connecting the electrode assembly 100 to an external stimulator 122, and stimulating the electrode assembly 100 at defined values of the operational parameters as disclosed herein.
- the method of treating psychiatric disorders comprises positioning the electrode assembly at a first region of a face of a patient, connecting the electrode assembly to an external stimulator, and stimulating the electrode assembly at defined values of the operational parameters as disclosed herein.
- the first region is a region corresponding to the auriculotemporal nerve.
- the first region is a region corresponding to the zygomaticofacial nerve.
- the first region is a region corresponding to the supraorbital nerve.
- 2-3A is stimulated at a stimulus frequency between about 20 Hz and about 300 Hz, at a pulse duration between 50 microseconds ( ⁇ ) and 250 ⁇ , at an output current density of less than 25 niA/cm 2 and an output charge density of less than 10 ⁇ 1 ⁇ / ⁇ 2 at the cerebral cortex for at least one-half to one hour per day.
- the stimulation would yield no or negligible charge densities at the cerebral
- stimulation can be provided for less than one-half hour per day.
- the stimulation is delivered at a specific pulse width or range of pulse widths (or pulse duration).
- the stimulation can be set to deliver pulse widths in any range within a lower limit of about 10 microseconds and an upper limit of about 3 seconds.
- the stimulation can be set to deliver pulse widths in the range greater than and/or less than one or more of 50 ⁇ , 60 ⁇ , 70 ⁇ , 80 ⁇ , 90 ⁇ , 100 ⁇ , 125 ⁇ , 150 ⁇ , 175 ⁇ , 200 ⁇ , 225 ⁇ , 250 ⁇ , up to 500 ⁇ .
- Those of skill in the art will recognized that one or more of the above times can be used as a border of a range of pulse widths.
- the stimulation amplitude is delivered as a voltage or current controlled stimulation. In other embodiments it can be delivered as a capacitive discharge.
- the current amplitude can be in any range within a lower limit of about 300 ⁇ and an upper limit of about 30mA-35mA, depending on the surface area of the electrodes, inter-electrode distance, the branch(es) stimulated, and the modeling data as described above..
- the amplitude can be in a range greater than and/or less than one or more of 50 ⁇ , 75 ⁇ , 100 ⁇ , 125 ⁇ , 150 ⁇ , 175 ⁇ , 200 ⁇ , 225 ⁇ , 250 ⁇ , 275 ⁇ , 300 ⁇ , 325 ⁇ , 350 ⁇ , 375 ⁇ , 400 ⁇ , 425 ⁇ , 450 ⁇ , 475 ⁇ , 500 ⁇ , 525 ⁇ , 550 ⁇ , 575 ⁇ , 600 ⁇ , 625 ⁇ , 650 ⁇ , 675 ⁇ , 700 ⁇ , 725 ⁇ , 850 ⁇ , 875 ⁇ , 900 ⁇ , 925 ⁇ , 950 ⁇ , 975 ⁇ , 1 mA, 2 ⁇ , 3 ⁇ , 4 ⁇ , 5 ⁇ , 6 ⁇ , 7 ⁇ , 8 ⁇ , 9 ⁇ , 10 mA, l lniA, 12mA, 13mA, 14mA, 15mA, 16mA, 17m
- the stimulation can be delivered at one or more frequencies, or within a range of frequencies.
- the stimulation can be set to be delivered at frequencies in any range within an upper limit of about 500 Hz and a lower limit of about 10 Hz.
- the stimulation can be set to be delivered at frequencies less than, and/or greater than one or more of 50 Hz, 45 Hz, 40 Hz, 35 Hz, 30 Hz, 25 Hz, 20 Hz, 15 Hz, or 10 Hz.
- the stimulation can be set to be delivered at frequencies greater than, and/or less than, one or more of 20Hz, 30Hz, 40Hz, 50 Hz, 60 Hz, 70 Hz, 80 Hz, 90 Hz, 100 Hz, 125 Hz, 150 Hz, up to 300 Hz.
- frequencies greater than, and/or less than, one or more of 20Hz, 30Hz, 40Hz, 50 Hz, 60 Hz, 70 Hz, 80 Hz, 90 Hz, 100 Hz, 125 Hz, 150 Hz, up to 300 Hz.
- the stimulation is delivered at a specific duty cycle or range of duty cycles within a range from 100% down to about 5%.
- the stimulation can be set to be delivered at a duty cycle in the range greater than and/or less than one or more of 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, or 100%.
- a duty cycle of 10% to 50% may be preferable.
- duty cycles up to 100% may be useful in particular circumstances. Those of skill in the art will recognize that one or more of the above percentages can be used as a border of a range of duty cycles.
- the values of the operational parameters are selected such that a patient will experience a stimulation sensation, such as a mild tingling over the forehead and scalp without being in discomfort or in pain.
- the neurostimulation parameters are important factors in the treatment method.
- the values of the operational parameters are selected to minimize skin irritation, burns, undesired effects on the brain and/or the ophthalmic nerves.
- the method of selecting operational parameters comprises evaluating variables such as the configuration and size of the electrode, the pulse duration, the electrode current, the duty cycle and the stimulation frequency, each of which are important factors in ensuring that the total charge, the charge density, and charge per phase are well within accepted safety limits for the skin, nerve and brain. For example, to minimize skin irritation, it is not sufficient to merely consider the total current, but the current density needs to be defined. Additionally, it is important to select the electrical stimulation parameters, electrode design, and inter-electrode distance, such that the electrical stimulation zone includes the ophthalmic nerve (approximately 3 -4mm deep), or other target nerve, while preventing or minimizing current penetration beneath the skull bone.
- variables such as the configuration and size of the electrode, the pulse duration, the electrode current, the duty cycle and the stimulation frequency, each of which are important factors in ensuring that the total charge, the charge density, and charge per phase are well within accepted safety limits for the skin, nerve and brain. For example, to minimize skin irritation, it is not sufficient to merely consider the total current, but
- the stimulation is carried out at the above-described values of the operational parameters.
- the values of the operational parameters are advantageously selected such that a patient will experience a stimulation sensation, such as mild tingling over the forehead and scalp, without causing the patient unbearable discomfort or pain. These values may vary according to the treatment of interest; however, the systems and devices disclosed herein stimulate at parameters where current penetration below the surface of the skull and/or into the brain is prevented or minimized.
- an external device may be used to identify the location of the branch or branches of the trigeminal nerve that will be targeted in an individual patient for stimulation by the implanted electrode assembly disclosed herein.
- the external device may be used for mapping and targeting the desired branch or branches of the trigeminal nerve and for identifying the individual stimulation parameters that are optimal for efficacy and safety.
- the device may include a plurality of external (transcutaneous) TNS electrodes. The practitioner approximates the location of the target branch and affixes the electrodes to the patient's skin above the target location. Stimulation may be applied and the actual location or preferred (optimal) stimulation location of the target branch or branches may be determined. Stimulation parameters may also be established. Once the location and/or stimulation parameters have been established via the external device, that data may be used to help guide the placement of the implanted electrodes for an individual patient and to establish the customized stimulation parameters for that patient.
- the use of external electrodes for stimulation of the trigeminal nerve may identify individuals who are likely to derive therapeutic benefit from a minimally invasive system in addition to the optimal specific locations and parameters of stimulation based on person-to-person variability.
- Various neurodiagnostic, imaging, or cutaneous nerve mapping methods may be able to delineate differences in individual anatomy to optimize stimulation for efficacy and/or safety.
- the use of a minimally invasive system may allow screening and identification of those individuals who are likely to derive benefit from other implantable systems, such as deep brain stimulation.
- stage I external TNS of the trigeminal nerve
- stage II implantanted TNS of the superficial trigeminal nerve
- stage III deep brain stimulation
- stage I can screen for stage II, and stage II for stage III.
- the results of treatment at one stage may be used to judge the likely effect of treatment with a more invasive treatment from a higher stage.
- the method may include applying a cutaneous system for stimulation of the trigeminal nerve to the patient and monitoring the patient for at least one of evidence of a useful therapeutic response or evidence of tolerability of TNS treatment, providing a subcutaneous electrode assembly or system, and implanting the subcutaneous electrode assembly or system in the patient for treatment of a
- a method of evaluating the use of deep brain stimulation for treatment of a neuropsychiatric disorder in a patient may include applying a cutaneous system for stimulation of the trigeminal nerve to the patient and monitoring the patient for at least one of evidence of a useful therapeutic response or evidence of tolerability of TNS treatment thereby generating external measurement criteria, providing a subcutaneous electrode assembly or system, implanting the subcutaneous electrode assembly or system in the patient for treatment of a neuropsychiatric disorder, monitoring the patient for at least one of a useful therapeutic response or tolerability of the implanted device, thereby generating extracranial measurement criteria, and analyzing the external measurement criteria and extracranial measurement criteria to determine whether the patient will benefit from deep brain stimulation.
- FIGS. 6A-6C illustrate the results from a pilot study of external trigeminal nerve stimulation for the treatment of depression.
- Subjects with major depression who met inclusion and exclusion criteria were followed for 8-weeks in an open label (unblinded) study conducted at UCLA.
- Inclusion Criteria were: Age 18-65 years old who met DSM-IV criteria for an acute, recurrent episode of Major Depressive Disorder (MDD) and were in a major depressive episode (MDE) of moderate severity.
- MDD Major Depressive Disorder
- MDE major depressive episode
- Other inclusion criteria were: the current MDE must be > 4 months in duration, no response to at least one antidepressant over at least six weeks during the current MDE, and concomitant use of at least one antidepressant.
- HDRS-28 Hamilton Depression Rating Scale
- Exclusion criteria were: current pregnancy; meeting DSM-IV criteria for atypical or psychotic or bipolar depression; a history of schizophrenia, schizoaffective disorder, or other non-mood disorder psychosis; a current secondary DSM-IV diagnosis (or signs) of delirium, dementia, amnestic disorder or other cognitive disorder; clinically significant current suicidal intent; significant cardiac, medical or progressive neurological or medical illness; facial pain or trigeminal neuralgia; a VNS or other implantable electrical device such as a pacemaker; current use of a TENS or VNS unit, or history of non-compliance.
- an electrical stimulator such as for example the EMS Model 7500 commercially available from TENS Products, Inc.
- the symptom severity of each subject was quantified using the Hamilton Depression Rating Scale (HDRS, scored using both 17- and 28-item versions), the Beck Depression Inventory (BDI), and the Quick Inventory of Depressive Symptomatology (QIDS), with the group average values on each of these scales being tabulated in the table shown in Fig. 6A. All three are assessment instruments designed to measure the severity of depression.
- HDRS Hamilton Depression Rating Scale
- BDI Beck Depression Inventory
- QIDS Quick Inventory of Depressive Symptomatology
- the HDRS is a well- established rating scale instrument which is filled out by a clinician after interviewing and observing the individual subject in order to measure the severity of depression; in this study, ratings on all 28 items (questions) were made, and the scale was scored according to standard methods using all items (HDRS2 8 ) and the standard subset of 17 items (HDRSn).
- the BDI is a 21 -question multiple choice self-report survey that is used to measure the severity of depression.
- the QIDS-C16 is a 16-question clinician-rated survey that is used to measure the severity of depression.
- BDI emphasizes cognitive symptoms of depression, while the HDRS weights neurovegetative symptoms prominently), and all are commonly used in clinical trials in major depression; the use of multiple scales allowed a more comprehensive assessment of the effects of trigeminal nerve stimulation than any single scale in this initial study of this treatment for major depression.
- FIG. 7 summarizes current, charge, current density and charge density recorded in a subject during exposure to cutaneous stimulation of the supraorbital nerve.
- Cutaneous electrical stimulation of the supraorbital branch of the trigeminal nerve with round 1.25-inch TENS patch electrodes results in current densities and charge density/phase that are well within the limits of safety.
- the maximum current comfortably tolerated by TNS patients studied previously is approximately 25 mA, and patients typically are stimulated at an amplitude setting well below 25 mA (6-10 mA).
- the 1.25-inch TENS electrodes are circular electrodes with a radius of 1.59 cm.
- typical stimulation current ranges from 6 - 10 mA at pulse durations of 150- 250usec.
- Charge Density (Charge density/phase): Yuen et al have identified a safe limit for charge density/phase delivered at the cerebral cortex of 40 uC/cm 2 . [Yuen et al 1981] and more recently McCreery et al. (McCreery et al 1990)have identified 10 uC/cm 2 as the safe limit. Assuming 10 mA at 250usec, the charge density/phase is [.010A] x
- [250usec]/7.92 0.32 uC/cm 2 at the stimulating electrode.
- the maximum charge density per phase is 0.79uC/cm 2 .
- the charge density is generally 12 to 120 fold less at the stimulating electrode than the maximum allowed at the cerebral cortex. Since the cortex is a minimum of 10-13 mm from the stimulating electrodes, and given the interposed layers of skin, fat, bone, dura, and CSF, the actual charge densities will be significantly lower. This is of importance in avoiding the undesired passage of current directly through brain tissue as a bulk conductor.
- the cutaneous electrode assembly of claim 1 further comprising a retainer element configured to secure the electrode assembly to a patient's forehead.
- the at least one branch of the trigeminal nerve is selected from the group consisting of: superficial ophthalmic branch, infraorbital branch, and mentalis branch.
- kits for trigeminal nerve stimulation for treatment of a neuropsychiatric disorder or condition comprising: the cutaneous electrode assembly according to claim 1 ; and instructions for placement of the electrode assembly on a patient for treatment of a neuropsychiatric disorder.
- a method for treating a neuropsychiatric disorder by trigeminal nerve stimulation comprising: attaching an electrode assembly to a patient, the electrode assembly comprising: a first pair of contacts configured for placement on a first region of the patient's face; a second pair of contacts configured for placement on a second region of the patient's face; and an insulating connection region connecting the first pair of contacts and the second pair of contacts, wherein the first pair of contacts and the second pair of contacts are configured to contact a portion of the patient's face overlying the cutaneous distribution of at least one branch of the trigeminal nerve; and applying electrical signals to the electrode assembly at specified operational parameters to treat a neuropsychiatric disorder with minimal current penetration below the skull bone.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Developmental Disabilities (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Social Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Electrotherapy Devices (AREA)
- Electroluminescent Light Sources (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10822563.2A EP2485798A4 (en) | 2009-10-05 | 2010-10-05 | Devices, systems and methods for treatment of neuropsychiatric disorders |
MX2012004050A MX337120B (en) | 2009-10-05 | 2010-10-05 | Devices, systems and methods for treatment of neuropsychiatric disorders. |
JP2012533256A JP2013506533A (en) | 2009-10-05 | 2010-10-05 | Apparatus, system and method for treating neuropsychiatric disorders |
AU2010303586A AU2010303586B2 (en) | 2009-10-05 | 2010-10-05 | Devices, systems and methods for treatment of neuropsychiatric disorders |
CA2776694A CA2776694C (en) | 2009-10-05 | 2010-10-05 | Devices, systems and methods for treatment of neuropsychiatric disorders |
BR112012008028A BR112012008028A2 (en) | 2009-10-05 | 2010-10-05 | trigeminal nerve stimulation system for treatment of a neuropsychiatric disorder, skin electrode unit, method for treating a neuropsychiatric disorder, and, trigeminal nerve stimulation kit for treatment of a neuropsychiatric disorder |
KR1020127011817A KR101749607B1 (en) | 2009-10-05 | 2010-10-05 | Systems, devices and methods for the treatment of neuropsychiatric disorders |
AU2015264876A AU2015264876B2 (en) | 2009-10-05 | 2015-12-03 | Devices, Systems and Methods for Treatment of Neuropsychiatric Disorders |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24882709P | 2009-10-05 | 2009-10-05 | |
US61/248,827 | 2009-10-05 | ||
US28982909P | 2009-12-23 | 2009-12-23 | |
US61/289,829 | 2009-12-23 | ||
US30551410P | 2010-02-17 | 2010-02-17 | |
US61/305,514 | 2010-02-17 | ||
US35464110P | 2010-06-14 | 2010-06-14 | |
US61/354,641 | 2010-06-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011044176A1 true WO2011044176A1 (en) | 2011-04-14 |
Family
ID=43857099
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/051544 WO2011044178A1 (en) | 2009-10-05 | 2010-10-05 | Extracranial implantable devices, systems and methods for the treatment of neurological disorders |
PCT/US2010/051545 WO2011044179A1 (en) | 2009-10-05 | 2010-10-05 | Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders |
PCT/US2010/051542 WO2011044176A1 (en) | 2009-10-05 | 2010-10-05 | Devices, systems and methods for treatment of neuropsychiatric disorders |
PCT/US2010/051539 WO2011044173A1 (en) | 2009-10-05 | 2010-10-05 | Systems, devices and methods for the treatment of neurological disorders and conditions |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/051544 WO2011044178A1 (en) | 2009-10-05 | 2010-10-05 | Extracranial implantable devices, systems and methods for the treatment of neurological disorders |
PCT/US2010/051545 WO2011044179A1 (en) | 2009-10-05 | 2010-10-05 | Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/051539 WO2011044173A1 (en) | 2009-10-05 | 2010-10-05 | Systems, devices and methods for the treatment of neurological disorders and conditions |
Country Status (9)
Country | Link |
---|---|
US (17) | US8958880B2 (en) |
EP (4) | EP2485799A4 (en) |
JP (8) | JP6035147B2 (en) |
KR (6) | KR101749605B1 (en) |
AU (4) | AU2010303586B2 (en) |
BR (4) | BR112012008028A2 (en) |
CA (4) | CA2776694C (en) |
MX (4) | MX337120B (en) |
WO (4) | WO2011044178A1 (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8880173B2 (en) | 2013-03-12 | 2014-11-04 | Ethicon Endo-Surgery, Inc. | Device for providing transdermal electrical stimulation at an adjustable position on a head |
US8958880B2 (en) | 2009-10-05 | 2015-02-17 | The Regents Of The University Of California | Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders |
JP2015513980A (en) * | 2012-04-05 | 2015-05-18 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Subcutaneous electrode for cranial nerve stimulation |
US9364674B2 (en) | 2010-11-30 | 2016-06-14 | Ian A. Cook | Pulse generator for cranial nerve stimulation |
US10238862B2 (en) | 2009-10-05 | 2019-03-26 | The Regents Of The University Of California | Extracranial implantable devices, systems and methods for the treatment of medical disorders |
US10258788B2 (en) | 2015-01-05 | 2019-04-16 | Thync Global, Inc. | Electrodes having surface exclusions |
US10293161B2 (en) | 2013-06-29 | 2019-05-21 | Thync Global, Inc. | Apparatuses and methods for transdermal electrical stimulation of nerves to modify or induce a cognitive state |
US10426945B2 (en) | 2015-01-04 | 2019-10-01 | Thync Global, Inc. | Methods and apparatuses for transdermal stimulation of the outer ear |
US10485972B2 (en) | 2015-02-27 | 2019-11-26 | Thync Global, Inc. | Apparatuses and methods for neuromodulation |
US10485971B2 (en) | 2014-10-31 | 2019-11-26 | Avent, Inc. | Non-invasive nerve stimulation system and method |
US10537703B2 (en) | 2012-11-26 | 2020-01-21 | Thync Global, Inc. | Systems and methods for transdermal electrical stimulation to improve sleep |
US10639468B2 (en) | 2009-10-05 | 2020-05-05 | The Regents Of The University Of California | Devices, systems and methods for the treatment of medical disorders |
US10646708B2 (en) | 2016-05-20 | 2020-05-12 | Thync Global, Inc. | Transdermal electrical stimulation at the neck |
US10814131B2 (en) | 2012-11-26 | 2020-10-27 | Thync Global, Inc. | Apparatuses and methods for neuromodulation |
US11033731B2 (en) | 2015-05-29 | 2021-06-15 | Thync Global, Inc. | Methods and apparatuses for transdermal electrical stimulation |
US11235148B2 (en) | 2015-12-18 | 2022-02-01 | Thync Global, Inc. | Apparatuses and methods for transdermal electrical stimulation of nerves to modify or induce a cognitive state |
US11278724B2 (en) | 2018-04-24 | 2022-03-22 | Thync Global, Inc. | Streamlined and pre-set neuromodulators |
US11534608B2 (en) | 2015-01-04 | 2022-12-27 | Ist, Llc | Methods and apparatuses for transdermal stimulation of the outer ear |
Families Citing this family (136)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7258690B2 (en) | 2003-03-28 | 2007-08-21 | Relievant Medsystems, Inc. | Windowed thermal ablation probe |
US6907884B2 (en) | 2002-09-30 | 2005-06-21 | Depay Acromed, Inc. | Method of straddling an intraosseous nerve |
US8361067B2 (en) | 2002-09-30 | 2013-01-29 | Relievant Medsystems, Inc. | Methods of therapeutically heating a vertebral body to treat back pain |
US10912712B2 (en) | 2004-03-25 | 2021-02-09 | The Feinstein Institutes For Medical Research | Treatment of bleeding by non-invasive stimulation |
US10028753B2 (en) | 2008-09-26 | 2018-07-24 | Relievant Medsystems, Inc. | Spine treatment kits |
WO2010036865A2 (en) | 2008-09-26 | 2010-04-01 | Relievant Medsystems, Inc. | Systems and methods for navigating an instrument through bone |
US9375571B2 (en) * | 2013-01-15 | 2016-06-28 | ElectroCore, LLC | Mobile phone using non-invasive nerve stimulation |
US20120220812A1 (en) * | 2011-02-27 | 2012-08-30 | Mishelevich David J | Ultrasound neuromodulation for stroke mitigation and rehabilitation |
US8702584B2 (en) * | 2010-05-12 | 2014-04-22 | Cefaly Technology Sprl | Neurostimulation method to induce relaxation or sleep |
DE102010030885A1 (en) * | 2010-07-02 | 2012-01-05 | Robert Bosch Gmbh | Method for controlling the power supply of an electric motor |
RU2013127313A (en) | 2010-11-16 | 2014-12-27 | Те Борд Оф Трастиз Оф Те Лилэнд Стэнфорд Джуниор Юниверсити | SYSTEMS AND METHODS FOR TREATING A DRY EYE |
US9821159B2 (en) | 2010-11-16 | 2017-11-21 | The Board Of Trustees Of The Leland Stanford Junior University | Stimulation devices and methods |
US9101769B2 (en) | 2011-01-03 | 2015-08-11 | The Regents Of The University Of California | High density epidural stimulation for facilitation of locomotion, posture, voluntary movement, and recovery of autonomic, sexual, vasomotor, and cognitive function after neurological injury |
CN106902457B (en) | 2011-01-28 | 2022-10-21 | 斯蒂维科技公司 | Neurostimulator system |
US8849412B2 (en) | 2011-01-28 | 2014-09-30 | Micron Devices Llc | Microwave field stimulator |
MX344095B (en) | 2011-03-24 | 2016-12-05 | Univ Louisville Res Found Inc | Neurostimulator. |
EP3586908A1 (en) | 2011-04-04 | 2020-01-01 | Micron Devices LLC | Implantable neural stimulator wireless lead |
US9220897B2 (en) | 2011-04-04 | 2015-12-29 | Micron Devices Llc | Implantable lead |
EP2524717A1 (en) * | 2011-05-14 | 2012-11-21 | cerboMed GmbH | Stimulation device |
DE102011101662A1 (en) * | 2011-05-14 | 2012-11-15 | Cerbomed Gmbh | stimulation device |
EP3747507B1 (en) | 2011-07-29 | 2023-11-01 | Curonix LLC | Remote control of power or polarity selection for a neural stimulator |
US8965511B2 (en) | 2011-08-30 | 2015-02-24 | Valencia Technologies Corporation | Implantable electroacupuncture system and method for reducing hypertension |
US9066845B2 (en) | 2012-03-06 | 2015-06-30 | Valencia Technologies Corporation | Electrode configuration for an implantable electroacupuncture device |
US8805512B1 (en) | 2011-08-30 | 2014-08-12 | Valencia Technologies Corporation | Implantable electroacupuncture device and method for reducing hypertension |
US9242103B2 (en) | 2011-09-15 | 2016-01-26 | Micron Devices Llc | Relay module for implant |
CA2848370C (en) | 2011-09-22 | 2020-01-14 | Djo, Llc | Devices and systems for treating pain with electrical stimulation |
US8996125B2 (en) | 2011-09-23 | 2015-03-31 | Valencia Technologies Corporation | Implantable electroacupuncture system and method for treating cardiovascular disease |
US8938297B2 (en) | 2011-09-23 | 2015-01-20 | Valencia Technologies Corporation | Implantable electroacupuncture device and method for treating cardiovascular disease |
US9198828B2 (en) | 2011-09-29 | 2015-12-01 | Valencia Technologies Corporation | Implantable electroacupuncture device and method for treating depression, bipolar disorder and anxiety |
US9173811B2 (en) | 2011-09-29 | 2015-11-03 | Valencia Technologies Corporation | Implantable electroacupuncture system and method for treating depression and similar mental conditions |
AU2012325856A1 (en) * | 2011-10-19 | 2014-06-05 | Gary L. Byars | Self directing stimulation electrode |
US10092750B2 (en) | 2011-11-11 | 2018-10-09 | Neuroenabling Technologies, Inc. | Transcutaneous neuromodulation system and methods of using same |
MX341649B (en) | 2011-11-11 | 2016-08-29 | Neuroenabling Tech Inc | Non invasive neuromodulation device for enabling recovery of motor, sensory, autonomic, sexual, vasomotor and cognitive function. |
RU2506968C2 (en) * | 2011-11-30 | 2014-02-20 | Федеральное Государственное бюджетное учреждение "Санкт-Петербургский научно-исследовательский психоневрологический институт им. В.М. Бехтерева" (НИПИ им. В.М. Бехтерева) | Method of treating vegetative state |
US20130147381A1 (en) * | 2011-12-08 | 2013-06-13 | Shenzhen China Star Optoelectronics Technology Co., Ltd. | Driving circuit and driving method for light emitting diode and display apparatus using the same |
US10390877B2 (en) | 2011-12-30 | 2019-08-27 | Relievant Medsystems, Inc. | Systems and methods for treating back pain |
US9314399B2 (en) | 2012-03-06 | 2016-04-19 | Valencia Technologies Corporation | Implantable electroacupuncture system and method for treating dyslipidemia and obesity |
US9364390B2 (en) | 2012-03-06 | 2016-06-14 | Valencia Technologies Corporation | Implantable electroacupuncture device and method for treating obesity |
US9078801B2 (en) | 2012-03-06 | 2015-07-14 | Valencia Technologies Corporation | Implantable electroacupuncture device and method for treating erectile dysfunction |
US9433786B2 (en) | 2012-03-06 | 2016-09-06 | Valencia Technologies Corporation | Implantable electroacupuncture system and method for treating Parkinson's disease and essential tremor |
US8954143B2 (en) | 2012-03-06 | 2015-02-10 | Valencia Technologies Corporation | Radial feed through packaging for an implantable electroacupuncture device |
US8942816B2 (en) | 2012-03-06 | 2015-01-27 | Valencia Technologies Corporation | Implantable electroacupuncture device and method for treating dyslipidemia |
US9327134B2 (en) | 2012-03-12 | 2016-05-03 | Valencia Technologies Corporation | Implantable electroacupuncture device and method |
US9827421B2 (en) | 2012-03-12 | 2017-11-28 | Valencia Technologies Corporation | Methods and systems for treating a chronic low back pain condition using an implantable electroacupuncture device |
US8942808B2 (en) | 2012-03-12 | 2015-01-27 | Valencia Technologies Corporation | Stimulation paradigm to improve blood pressure dipping in an implantable electroacupuncture device |
US9089716B2 (en) | 2012-03-12 | 2015-07-28 | Valencia Technologies Corporation | Circuits and methods for using a high impedance, thin, coin-cell type battery in an implantable electroacupuncture device |
WO2013165697A1 (en) * | 2012-04-30 | 2013-11-07 | Vigilant Medical Solutions, Inc. | Indirect and non-invasive trigeminal neuromodulation for the treatment of disease |
CA2872472C (en) | 2012-05-03 | 2021-05-04 | Ioannis Mihail Skaribas | External, head-worn electrical stimulator for treating headache conditions |
US10588691B2 (en) | 2012-09-12 | 2020-03-17 | Relievant Medsystems, Inc. | Radiofrequency ablation of tissue within a vertebral body |
US9724512B2 (en) | 2012-09-28 | 2017-08-08 | Valencia Technologies Corporation | Implantable electroacupuncture system and method for treating parkinson's disease and essential tremor through application of stimului at or near an acupoint on the chorea line |
JP6195625B2 (en) | 2012-11-05 | 2017-09-13 | リリーバント メドシステムズ、インコーポレイテッド | System and method for creating a curved pathway through bone and regulating nerves within the bone |
US9440070B2 (en) | 2012-11-26 | 2016-09-13 | Thyne Global, Inc. | Wearable transdermal electrical stimulation devices and methods of using them |
US9399126B2 (en) | 2014-02-27 | 2016-07-26 | Thync Global, Inc. | Methods for user control of neurostimulation to modify a cognitive state |
CN204147427U (en) * | 2012-11-26 | 2015-02-11 | 塞恩克公司 | Wearable electrocutaneous stimulation equipment |
EP2938393A1 (en) | 2012-12-26 | 2015-11-04 | Micron Devices, LLC | Wearable antenna assembly |
AU2014207265B2 (en) | 2013-01-21 | 2017-04-20 | Cala Health, Inc. | Devices and methods for controlling tremor |
US10220211B2 (en) | 2013-01-22 | 2019-03-05 | Livanova Usa, Inc. | Methods and systems to diagnose depression |
WO2014165124A1 (en) | 2013-03-12 | 2014-10-09 | Oculeve, Inc. | Implant delivery devices, systems, and methods |
US9259576B2 (en) | 2013-03-12 | 2016-02-16 | University Health Network | Functional electrical stimulation method, use and apparatus for mood alteration |
JP5345256B1 (en) * | 2013-03-26 | 2013-11-20 | 謙輔 山川 | Electrical stimulator |
WO2014172381A1 (en) * | 2013-04-15 | 2014-10-23 | Neurometrix Inc. | Transcutaneous electrical nerves stimulator with automatic detection of user sleep-wake state |
WO2014172693A2 (en) | 2013-04-19 | 2014-10-23 | Oculeve, Inc. | Nasal stimulation devices and methods |
AU2014257024B2 (en) * | 2013-04-24 | 2019-05-09 | Neurosigma, Inc. | Modulation of autonomic nervous system activity and integrated electrode assemblies for trigeminal neurostimulation |
KR101470588B1 (en) * | 2013-05-24 | 2014-12-10 | 고려대학교 산학협력단 | Apparatus and method for brain-brain interfacing |
WO2014189327A1 (en) * | 2013-05-24 | 2014-11-27 | 고려대학교 산학협력단 | Ultrasonic wave output system for treating brain-brain interface and method therefor |
CN105934261B (en) * | 2013-06-29 | 2019-03-08 | 赛威医疗公司 | For changing or induction cognitive state transcutaneous electrostimulation device and method |
US9427595B2 (en) * | 2013-07-10 | 2016-08-30 | Pacesetter, Inc. | Neurostimulation patch |
US9724151B2 (en) | 2013-08-08 | 2017-08-08 | Relievant Medsystems, Inc. | Modulating nerves within bone using bone fasteners |
US9839777B2 (en) | 2013-08-14 | 2017-12-12 | Syntilla Medical LLC | Implantable neurostimulation lead for head pain |
US9042991B2 (en) | 2013-08-14 | 2015-05-26 | Syntilla Medical LLC | Implantable head mounted neurostimulation system for head pain |
US9427566B2 (en) * | 2013-08-14 | 2016-08-30 | Syntilla Medical LLC | Implantable neurostimulation lead for head pain |
US9498635B2 (en) | 2013-10-16 | 2016-11-22 | Syntilla Medical LLC | Implantable head located radiofrequency coupled neurostimulation system for head pain |
US10258805B2 (en) | 2013-10-23 | 2019-04-16 | Syntilla Medical, Llc | Surgical method for implantable head mounted neurostimulation system for head pain |
US10960215B2 (en) | 2013-10-23 | 2021-03-30 | Nuxcel, Inc. | Low profile head-located neurostimulator and method of fabrication |
US20150217120A1 (en) | 2014-01-13 | 2015-08-06 | Mandheerej Nandra | Neuromodulation systems and methods of using same |
US9770583B2 (en) | 2014-02-25 | 2017-09-26 | Oculeve, Inc. | Polymer formulations for nasolacrimal stimulation |
EP3142743B1 (en) | 2014-05-12 | 2020-07-29 | Stimwave Technologies Incorporated | Remote rf power system with low profile transmitting antenna |
JP6701096B2 (en) | 2014-05-17 | 2020-05-27 | ハイイン エクイティ インベストメント ファンド エル.ピー. | Method and apparatus for ensemble waveform application using transcutaneous nerve stimulation |
WO2015183620A2 (en) | 2014-05-25 | 2015-12-03 | Thync, Inc. | Wearable transdermal neurostimulators |
US9333334B2 (en) | 2014-05-25 | 2016-05-10 | Thync, Inc. | Methods for attaching and wearing a neurostimulator |
AU2015271774B2 (en) | 2014-06-02 | 2020-04-16 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor |
US10130809B2 (en) | 2014-06-13 | 2018-11-20 | Nervana, LLC | Transcutaneous electrostimulator and methods for electric stimulation |
US9782584B2 (en) | 2014-06-13 | 2017-10-10 | Nervana, LLC | Transcutaneous electrostimulator and methods for electric stimulation |
JP6643313B2 (en) | 2014-07-25 | 2020-02-12 | オキュリーブ, インコーポレイテッド | Stimulation patterns for treating dry eye |
US12053630B2 (en) | 2014-08-17 | 2024-08-06 | Coloplast A/S | Implantable pulse generator with automatic jump-start |
WO2016028608A1 (en) | 2014-08-17 | 2016-02-25 | Nine Continents Medical, Inc. | Miniature implatable neurostimulator system for sciatic nerves and their branches |
WO2016044659A1 (en) * | 2014-09-17 | 2016-03-24 | Neurosigma, Inc. | Template for trigeminal neurostimulation |
EP3209371A4 (en) | 2014-10-22 | 2018-10-24 | Oculeve, Inc. | Implantable nasal stimulator systems and methods |
BR112017008267A2 (en) | 2014-10-22 | 2017-12-19 | Oculeve Inc | Devices and methods for treating dry eye |
CA2965514A1 (en) | 2014-10-22 | 2016-04-28 | Oculeve, Inc. | Contact lens for increasing tear production |
WO2016081767A1 (en) * | 2014-11-19 | 2016-05-26 | Neurosigma, Inc. | Trigeminal neurostimulation based upon pulse counting and chronobiology |
DE102015004064A1 (en) * | 2015-03-28 | 2016-09-29 | Albrecht Molsberger | Therapeutically applicable DC delivery device with a plurality of flat structures |
EP3277369B1 (en) | 2015-03-30 | 2019-12-25 | CEFALY Technology Sprl | Device for the transcutaneous electrical stimulation of the trigeminal nerve |
CN112915380A (en) | 2015-06-10 | 2021-06-08 | 卡拉健康公司 | System and method for peripheral nerve stimulation to treat tremor with a detachable treatment and monitoring unit |
WO2017053847A1 (en) | 2015-09-23 | 2017-03-30 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation in the finger or hand to treat hand tremors |
WO2017059367A1 (en) | 2015-10-02 | 2017-04-06 | The Regents Of The University Of California | System and method for optical transient liquid molding of microparticles and uses for the same |
US10426958B2 (en) | 2015-12-04 | 2019-10-01 | Oculeve, Inc. | Intranasal stimulation for enhanced release of ocular mucins and other tear proteins |
US9956405B2 (en) | 2015-12-18 | 2018-05-01 | Thyne Global, Inc. | Transdermal electrical stimulation at the neck to induce neuromodulation |
US9717917B2 (en) | 2016-01-06 | 2017-08-01 | Syntilla Medical LLC | Charging system incorporating independent charging and communication with multiple implanted devices |
IL286747B2 (en) | 2016-01-21 | 2024-05-01 | Cala Health Inc | Wearable device for treating urinary symptoms |
GB201601536D0 (en) * | 2016-01-27 | 2016-03-09 | Neurolief Ltd | Resilient head mounted device for neurostimulation and sensing of body parameters |
US10252048B2 (en) | 2016-02-19 | 2019-04-09 | Oculeve, Inc. | Nasal stimulation for rhinitis, nasal congestion, and ocular allergies |
US11406558B2 (en) | 2016-04-25 | 2022-08-09 | Preactive Technologies Inc. | Reducing brain injury by limiting brain motion during sudden deceleration or acceleration of the head |
US12041997B2 (en) | 2016-04-25 | 2024-07-23 | Preactive Technologies Inc. | Reducing brain injury by limiting brain motion during sudden deceleration or acceleration of the head |
CA3022683A1 (en) | 2016-05-02 | 2017-11-09 | Oculeve, Inc. | Intranasal stimulation for treatment of meibomian gland disease and blepharitis |
IL264116B2 (en) | 2016-07-08 | 2024-01-01 | Cala Health Inc | Systems and methods for stimulating n nerves with exactly n electrodes and improved dry electrodes |
US20180070870A1 (en) * | 2016-09-09 | 2018-03-15 | The Board Of Trustees Of The Leland Stanford Junior University | Autonomous Sweat Extraction and Analysis Using a Fully-Integrated Wearable Platform |
EP3533486B1 (en) | 2016-10-31 | 2020-12-09 | Y-Brain Inc | Electrical stimulation apparatus |
CN110022755A (en) | 2016-12-02 | 2019-07-16 | 奥库利维公司 | Device and method for xerophthalmia prediction and treatment recommendations |
WO2018129351A1 (en) | 2017-01-05 | 2018-07-12 | Shriram Raghunathan | Restless leg syndrome or overactive nerve treatment |
US11103691B2 (en) | 2019-10-03 | 2021-08-31 | Noctrix Health, Inc. | Peripheral nerve stimulation for restless legs syndrome |
CA3058786A1 (en) | 2017-04-03 | 2018-10-11 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder |
DE202018001803U1 (en) | 2017-05-19 | 2018-06-27 | Cefaly Technology Sprl | External trigeminal nerve stimulation for the acute treatment of migraine attacks |
EP3695880B8 (en) | 2017-06-30 | 2021-08-18 | ONWARD Medical B.V. | System for neuromodulation |
EP3720338A1 (en) | 2017-12-05 | 2020-10-14 | Ecole Polytechnique Federale de Lausanne (EPFL) | A system for planning and/or providing neuromodulation |
WO2019143790A1 (en) | 2018-01-17 | 2019-07-25 | Cala Health, Inc. | Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation |
US11467665B2 (en) | 2018-06-14 | 2022-10-11 | Meron Gribetz | Virtual user interface system and methods for use thereof |
WO2020035852A2 (en) * | 2018-08-14 | 2020-02-20 | Neurotrigger Ltd. | Method and apparatus for transcutaneous facial nerve stimulation and applications thereof |
US11260229B2 (en) | 2018-09-25 | 2022-03-01 | The Feinstein Institutes For Medical Research | Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation |
EP3643357A1 (en) * | 2018-10-25 | 2020-04-29 | PreActive Technologies Inc. | Reducing brain injury by limiting brain motion during sudden deceleration or acceleration of the head |
EP3653256B1 (en) | 2018-11-13 | 2022-03-30 | ONWARD Medical N.V. | Control system for movement reconstruction and/or restoration for a patient |
DE18205817T1 (en) | 2018-11-13 | 2020-12-24 | Gtx Medical B.V. | SENSOR IN CLOTHING OF LIMBS OR FOOTWEAR |
US20220118253A1 (en) * | 2019-01-18 | 2022-04-21 | Ist, Llc | Systems and methods for craniocervical and auricular neuromodulation |
EP3695878B1 (en) | 2019-02-12 | 2023-04-19 | ONWARD Medical N.V. | A system for neuromodulation |
AU2020234772A1 (en) * | 2019-03-13 | 2021-11-11 | Shiratronics, Inc. | Implantable neurostimulator to treat chronic migraine headaches |
US11065461B2 (en) | 2019-07-08 | 2021-07-20 | Bioness Inc. | Implantable power adapter |
US11911620B2 (en) * | 2019-07-22 | 2024-02-27 | Ismail Mohammed Yousif Musallam | Neuromodulation for treatment of brain and eye strokes and/or acute dysregulated reduced cerebral or ocular blood flow |
CA3150339A1 (en) | 2019-09-12 | 2021-03-18 | Brian W. Donovan | Systems and methods for tissue modulation |
JP7369435B2 (en) * | 2019-09-24 | 2023-10-26 | 学校法人関西医科大学 | Neurological function improvement device |
US11890468B1 (en) | 2019-10-03 | 2024-02-06 | Cala Health, Inc. | Neurostimulation systems with event pattern detection and classification |
DE19211698T1 (en) | 2019-11-27 | 2021-09-02 | Onward Medical B.V. | Neuromodulation system |
JP6845445B2 (en) * | 2019-12-27 | 2021-03-17 | 国立大学法人千葉大学 | Devices and methods for applying electrical stimulation to the retina |
AU2021409967A1 (en) | 2020-12-22 | 2023-08-03 | Relievant Medsystems, Inc. | Prediction of candidates for spinal neuromodulation |
WO2024002448A1 (en) | 2022-06-29 | 2024-01-04 | Alpha Holding Brande Aps | Elevated pressure hybrid wood modification |
WO2024155471A1 (en) * | 2023-01-17 | 2024-07-25 | Carnegie Mellon University | System and method for training a subject to self-regulate neural variability |
CN116077789A (en) * | 2023-04-07 | 2023-05-09 | 深圳尤尼智康医疗科技有限公司 | Comprehensive brain disease intervention system with hydrogen or oxygen absorption and nasal and brain route administration functions |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4233986A (en) * | 1978-07-18 | 1980-11-18 | Agar Ginosar Electronics And Metal Products | Apparatus and method for controlling pain by transcutaneous electrical stimulation (TES) |
US20060064140A1 (en) * | 2001-01-30 | 2006-03-23 | Whitehurst Todd K | Methods and systems for stimulating a trigeminal nerve to treat a psychiatric disorder |
US20060167500A1 (en) * | 2002-08-19 | 2006-07-27 | Bruce Towe | Neurostimulator |
WO2008128215A1 (en) * | 2007-04-13 | 2008-10-23 | Alejandro Covalin | Apparatus and method for the treatment of headache |
Family Cites Families (117)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3279468A (en) * | 1963-05-14 | 1966-10-18 | Vine Sidney Le | Electrotherapeutic facial mask apparatus |
US3709228A (en) * | 1971-01-07 | 1973-01-09 | D Barker | Apparatus for facial stimulation |
US4305402A (en) | 1979-06-29 | 1981-12-15 | Katims Jefferson J | Method for transcutaneous electrical stimulation |
US4635641A (en) | 1985-10-16 | 1987-01-13 | Murray Electronics Associates Limited | Multi-element electrode |
JPH0310963Y2 (en) * | 1986-04-17 | 1991-03-18 | ||
SU1718976A1 (en) | 1989-10-31 | 1992-03-15 | 1-Й Московский Медицинский Институт Им.И.М.Сеченова | Method for alleviating pains in cases of trifacial neuralgia |
RU2086227C1 (en) | 1994-04-05 | 1997-08-10 | Российский научно-исследовательский нейрохирургический институт им.проф.А.Л.Поленова | Method for treating neurovascular orbital structures injuries |
JPH07289649A (en) * | 1994-04-22 | 1995-11-07 | Hayashibara Takeshi | Stimulant signal generation device for ocular nerve |
US5540734A (en) * | 1994-09-28 | 1996-07-30 | Zabara; Jacob | Cranial nerve stimulation treatments using neurocybernetic prosthesis |
US5514175A (en) * | 1994-11-09 | 1996-05-07 | Cerebral Stimulation, Inc. | Auricular electrical stimulator |
US5549734A (en) | 1995-03-08 | 1996-08-27 | Astec Industries, Inc. | Baghouse cleaning method |
JPH08299141A (en) | 1995-05-08 | 1996-11-19 | Mori Mihoko | Pillow cover |
US5814095A (en) | 1996-09-18 | 1998-09-29 | Implex Gmbh Spezialhorgerate | Implantable microphone and implantable hearing aids utilizing same |
US6016449A (en) | 1997-10-27 | 2000-01-18 | Neuropace, Inc. | System for treatment of neurological disorders |
US20070060975A1 (en) * | 1999-07-08 | 2007-03-15 | Mannheimer Jeffrey S | Combination electrode-battery and programming assembly for a miniature wireless transcutaneous electrical neuro or muscular-stimulation unit |
US7200446B2 (en) * | 1999-07-21 | 2007-04-03 | Borkan William N | Catheter leads for the intrathecal space and method of use |
US6567702B1 (en) * | 1999-10-15 | 2003-05-20 | The Board Of Trustees Of The Leland Stanford Junior University | Eliciting analgesia by transcranial electrical stimulation |
US6466822B1 (en) | 2000-04-05 | 2002-10-15 | Neuropace, Inc. | Multimodal neurostimulator and process of using it |
US6405079B1 (en) * | 2000-09-22 | 2002-06-11 | Mehdi M. Ansarinia | Stimulation method for the dural venous sinuses and adjacent dura for treatment of medical conditions |
US7158832B2 (en) | 2000-09-27 | 2007-01-02 | Cvrx, Inc. | Electrode designs and methods of use for cardiovascular reflex control devices |
US6549808B1 (en) * | 2000-10-19 | 2003-04-15 | Heinz R. Gisel | Devices and methods for the transcutaneous delivery of ions and the electrical stimulation of tissue and cells at targeted areas in the eye |
US6950707B2 (en) * | 2000-11-21 | 2005-09-27 | Advanced Bionics Corporation | Systems and methods for treatment of obesity and eating disorders by electrical brain stimulation and/or drug infusion |
RU2185092C1 (en) | 2000-12-21 | 2002-07-20 | Ремнев Андрей Геннадьевич | Method for diagnosing the first and the second trigeminus nerve branch injuries |
US6788975B1 (en) * | 2001-01-30 | 2004-09-07 | Advanced Bionics Corporation | Fully implantable miniature neurostimulator for stimulation as a therapy for epilepsy |
US6735475B1 (en) * | 2001-01-30 | 2004-05-11 | Advanced Bionics Corporation | Fully implantable miniature neurostimulator for stimulation as a therapy for headache and/or facial pain |
US7171276B2 (en) * | 2001-06-29 | 2007-01-30 | Abbott Laboratories | Hydrogel and scrim assembly for use with electro-acupuncture device with stimulation electrodes |
US20030045922A1 (en) * | 2001-08-29 | 2003-03-06 | Nancy Northrop | Skin treatment method and apparatus |
US20140046407A1 (en) * | 2001-08-31 | 2014-02-13 | Bio Control Medical (B.C.M.) Ltd. | Nerve stimulation techniques |
US8565896B2 (en) * | 2010-11-22 | 2013-10-22 | Bio Control Medical (B.C.M.) Ltd. | Electrode cuff with recesses |
US6954668B1 (en) * | 2001-10-11 | 2005-10-11 | Cuozzo John W | Apparatus and method for intra-oral stimulation of the trigeminal nerve |
US7689277B2 (en) | 2002-03-22 | 2010-03-30 | Leptos Biomedical, Inc. | Neural stimulation for treatment of metabolic syndrome and type 2 diabetes |
US20030195588A1 (en) | 2002-04-16 | 2003-10-16 | Neuropace, Inc. | External ear canal interface for the treatment of neurological disorders |
US7003352B1 (en) | 2002-05-24 | 2006-02-21 | Advanced Bionics Corporation | Treatment of epilepsy by brain stimulation |
JP2003339884A (en) | 2002-05-31 | 2003-12-02 | Fes:Kk | Electric stimulating apparatus for face |
US7158834B2 (en) * | 2002-06-13 | 2007-01-02 | Atlantic Medical, Inc. | Method and apparatus for performing microcurrent stimulation (MSC) therapy |
WO2003105945A2 (en) * | 2002-06-13 | 2003-12-24 | Paul Edward L Jr | Transcutaneous electrical nerve stimulation device and method using microcurrent |
US20040138097A1 (en) * | 2002-11-01 | 2004-07-15 | Bahman Guyuron | Method and treatment for treating and preventing pain associated with compression of a nerve |
US20040243207A1 (en) * | 2003-05-30 | 2004-12-02 | Olson Donald R. | Medical implant systems |
US7209791B2 (en) * | 2003-08-16 | 2007-04-24 | Joseph Odom | Electromagnetic delivery system to influence a biological system |
US8190248B2 (en) * | 2003-10-16 | 2012-05-29 | Louisiana Tech University Foundation, Inc. | Medical devices for the detection, prevention and/or treatment of neurological disorders, and methods related thereto |
US7769461B2 (en) * | 2003-12-19 | 2010-08-03 | Boston Scientific Neuromodulation Corporation | Skull-mounted electrical stimulation system and method for treating patients |
JP4879754B2 (en) * | 2004-01-22 | 2012-02-22 | リハブトロニクス インコーポレーテッド | Method for carrying electrical current to body tissue via implanted non-active conductor |
US7844344B2 (en) * | 2004-03-30 | 2010-11-30 | Medtronic, Inc. | MRI-safe implantable lead |
US7565197B2 (en) * | 2004-06-18 | 2009-07-21 | Medtronic, Inc. | Conditional requirements for remote medical device programming |
EP1786510A4 (en) | 2004-07-15 | 2009-12-02 | Northstar Neuroscience Inc | Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy |
US20060050912A1 (en) | 2004-09-09 | 2006-03-09 | Earcraft, Inc. | Shell and tip for hearing aid |
WO2006034305A2 (en) * | 2004-09-21 | 2006-03-30 | University Of Florida Research Foundation, Inc. | Multiple lead method for deep brain stimulation |
CA2626691A1 (en) | 2004-10-18 | 2006-04-27 | Louisiana Tech University Foundation | Medical devices for the detection, prevention and/or treatment of neurological disorders, and methods related thereto |
US7685817B2 (en) | 2004-10-18 | 2010-03-30 | Ceti, Inc. | Method and system for providing a rotational output using a non-combustion heat source |
WO2006047265A1 (en) * | 2004-10-21 | 2006-05-04 | Advanced Neuromodulation Systems, Inc. | Stimulation of the amygdalophippocampal complex to treat neurological conditions |
FR2877583B1 (en) * | 2004-11-10 | 2007-05-11 | Patrick Cosson | ELECTROTHERAPY DEVICE |
EP1671670A1 (en) * | 2004-12-14 | 2006-06-21 | STX Sprl | Apparatus for electrically inhibiting facial muscles |
US8825166B2 (en) | 2005-01-21 | 2014-09-02 | John Sasha John | Multiple-symptom medical treatment with roving-based neurostimulation |
DE102005003735B4 (en) | 2005-01-26 | 2008-04-03 | Cerbomed Gmbh | Device for transcutaneous stimulation of a nerve of the human body |
US8700163B2 (en) | 2005-03-04 | 2014-04-15 | Cyberonics, Inc. | Cranial nerve stimulation for treatment of substance addiction |
US20080275327A1 (en) * | 2005-03-09 | 2008-11-06 | Susanne Holm Faarbaek | Three-Dimensional Adhesive Device Having a Microelectronic System Embedded Therein |
US7920915B2 (en) * | 2005-11-16 | 2011-04-05 | Boston Scientific Neuromodulation Corporation | Implantable stimulator |
US20060206165A1 (en) * | 2005-03-14 | 2006-09-14 | Jaax Kristen N | Occipital nerve stimulation to treat headaches and other conditions |
US7853321B2 (en) | 2005-03-14 | 2010-12-14 | Boston Scientific Neuromodulation Corporation | Stimulation of a stimulation site within the neck or head |
EP1861160B1 (en) * | 2005-03-24 | 2011-11-16 | Metacure Limited | Wireless leads for gastrointestinal tract applications |
US7499752B2 (en) | 2005-07-29 | 2009-03-03 | Cyberonics, Inc. | Selective nerve stimulation for the treatment of eating disorders |
US20070025608A1 (en) | 2005-07-29 | 2007-02-01 | Cyberonics, Inc. | Enhancing intrinsic neural activity using a medical device to treat a patient |
JP2007054299A (en) | 2005-08-24 | 2007-03-08 | Sharp Corp | Electrotherapy apparatus and system for constituting the same |
JP2007061267A (en) | 2005-08-30 | 2007-03-15 | Nova Medico:Kk | Device for treating rhinitis or conjunctivitis |
US20070150027A1 (en) * | 2005-12-22 | 2007-06-28 | Rogers Lesco L | Non-invasive device and method for electrical stimulation of neural tissue |
US8725243B2 (en) * | 2005-12-28 | 2014-05-13 | Cyberonics, Inc. | Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders |
US20070173908A1 (en) * | 2006-01-20 | 2007-07-26 | Cyberonics, Inc. | Transcutaneous trigeminal nerve stimulation to treat motion sickness |
WO2007083275A1 (en) * | 2006-01-23 | 2007-07-26 | Koninklijke Philips Electronics N.V. | Improved biomedical electrode for extended patient wear featuring a tap, or snap, which is isolated from the retention seal |
US7801601B2 (en) * | 2006-01-27 | 2010-09-21 | Cyberonics, Inc. | Controlling neuromodulation using stimulus modalities |
GB0603464D0 (en) | 2006-02-21 | 2006-04-05 | Goreszeniuk Teodor | Improvements in & relating to external neurostimulation |
JP5052596B2 (en) * | 2006-03-29 | 2012-10-17 | ディグニティー ヘルス | Synchronization of vagus nerve stimulation by patient's cardiac cycle |
JP2009537226A (en) | 2006-05-18 | 2009-10-29 | エヌディーアイ メディカル, エルエルシー | Portable assembly, system, and method for providing functional or therapeutic neural stimulation |
US20080128215A1 (en) | 2006-05-24 | 2008-06-05 | Gershon Nowitz | Portable Scissor Lift |
US8909342B2 (en) | 2006-08-15 | 2014-12-09 | Andres M. Lozano | Method for treating eating disorders |
US7940933B2 (en) * | 2006-08-18 | 2011-05-10 | Medtronic, Inc. | Secure telemetric link |
US7774072B2 (en) * | 2006-11-30 | 2010-08-10 | Medtronic, Inc. | Attached implantable medical elongated members |
US20080140151A1 (en) * | 2006-12-11 | 2008-06-12 | Brodkey Jason A | Nerve stimulation apparatus and method for the treatment of head pain |
KR101247409B1 (en) * | 2006-12-15 | 2013-03-25 | 나소플렉스 비. 브이. | Resuscitation device and method for resuscitation |
US7890178B2 (en) * | 2006-12-15 | 2011-02-15 | Medtronic Xomed, Inc. | Method and apparatus for assisting deglutition |
US9913593B2 (en) * | 2006-12-27 | 2018-03-13 | Cyberonics, Inc. | Low power device with variable scheduling |
US20080171929A1 (en) | 2007-01-11 | 2008-07-17 | Katims Jefferson J | Method for standardizing spacing between electrodes, and medical tape electrodes |
US8696724B2 (en) * | 2007-01-11 | 2014-04-15 | Scion Neurostim, Llc. | Devices for vestibular or cranial nerve stimulation |
CA2677364A1 (en) * | 2007-02-05 | 2008-08-14 | University Of Southern California | Treatment of consumption disorders with biostimulation |
US7949403B2 (en) * | 2007-02-27 | 2011-05-24 | Accelerated Care Plus Corp. | Electrical stimulation device and method for the treatment of neurological disorders |
JP4961558B2 (en) * | 2007-03-30 | 2012-06-27 | 国立大学法人信州大学 | Trigeminal nerve perceptual branch stimulator |
US20080262566A1 (en) * | 2007-04-23 | 2008-10-23 | Boston Scientific Neuromodulation Corporation | Methods and systems of treating medication overuse headache |
US8954162B2 (en) * | 2007-04-25 | 2015-02-10 | Medtronic, Inc. | Medical device implantation |
EP2164389B1 (en) * | 2007-07-06 | 2013-06-19 | Koninklijke Philips Electronics N.V. | Shielded biomedical electrode patch |
EP2195084A4 (en) * | 2007-09-26 | 2010-10-20 | Univ Duke | Method of treating parkinson's disease and other movement disorders |
EP2222370A1 (en) * | 2007-10-24 | 2010-09-01 | Medtronic, Inc. | Transmission of power source usage information over a network |
US8849407B1 (en) * | 2008-01-04 | 2014-09-30 | Yuri P. Danilov | Non-invasive neuromodulation (NINM) for rehabilitation of brain function |
EP2092951A1 (en) * | 2008-02-20 | 2009-08-26 | Stx-Med Sprl | Device for electrotherapeutical treatment of tension headaches |
PL2320997T3 (en) * | 2008-05-13 | 2016-05-31 | Cerbomed Gmbh | Apparatus to enhance neural tissue operation |
US20090326602A1 (en) | 2008-06-27 | 2009-12-31 | Arkady Glukhovsky | Treatment of indications using electrical stimulation |
EP3586923B1 (en) * | 2008-07-14 | 2021-06-16 | Arizona Board Of Regents For And On Behalf Of Arizona State University | Devices for modulating cellular activity using ultrasound |
US20100030227A1 (en) * | 2008-07-31 | 2010-02-04 | Medtronic, Inc. | Medical lead implantation |
US8512715B2 (en) * | 2008-08-14 | 2013-08-20 | The Cleveland Clinic Foundation | Apparatus and method for treating a neuromuscular defect |
US8280515B2 (en) * | 2008-09-16 | 2012-10-02 | Joshua Greenspan | Occipital neuromodulation |
AU2009307634B2 (en) * | 2008-10-21 | 2013-02-07 | Med-El Elektromedizinische Geraete Gmbh | System and method for facial nerve stimulation |
US8666498B2 (en) * | 2008-10-27 | 2014-03-04 | Serene Medical, Inc. | Treatment of headache |
DE102008043973B4 (en) | 2008-11-21 | 2011-12-01 | Burkhard Brocke | Device for transcranial neurostimulation |
US8494641B2 (en) * | 2009-04-22 | 2013-07-23 | Autonomic Technologies, Inc. | Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism |
US20110071595A1 (en) * | 2009-09-22 | 2011-03-24 | Muccio Philip | System for using electrical muscle stimulation to increase blood flow in body parts |
JP6035147B2 (en) | 2009-10-05 | 2016-11-30 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | System, apparatus and method for treating neurological disorders or conditions |
WO2012082961A2 (en) | 2010-12-14 | 2012-06-21 | The Regents Of The University Of California | Extracranial implantable devices, systems and methods for the treatment of medical disorders |
US9101766B2 (en) | 2009-10-16 | 2015-08-11 | The Board Of Trustees Of The Leland Stanford Junior University | Eliciting analgesia by transcranial electrical stimulation |
JP2013525069A (en) | 2010-05-02 | 2013-06-20 | レイク バイオサイエンシーズ リミテッド ライアビリティ カンパニー | Function adjustment method through the ear of the facial nervous system or related nerve structure |
US8702584B2 (en) * | 2010-05-12 | 2014-04-22 | Cefaly Technology Sprl | Neurostimulation method to induce relaxation or sleep |
CA2819346C (en) | 2010-11-30 | 2020-01-21 | Ian A. Cook | Pulse generator for cranial nerve stimulation |
KR20140037803A (en) | 2010-12-14 | 2014-03-27 | 더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 | Device, system and methods for the treatment of medical disorders |
US20120203301A1 (en) * | 2011-02-07 | 2012-08-09 | Advanced Neuromodulation Systems, Inc. | Methods using trigeminal nerve stimulation to treat neurological diseases |
US20140081369A1 (en) * | 2011-05-11 | 2014-03-20 | Alejandro Covalin | Headache-treatment device with gel dispensing kit and method |
BE1020458A3 (en) | 2012-01-13 | 2013-10-01 | Stx Med Sprl | AUTONOMOUS ELECTRONIC APPARATUS AND DIPOSITIVE FIXING THE SAME ON A LOCALIZED ELECTRODE AT THE HEAD FOR USE IN THE LAYERED POSITION OF THE PATIENT. |
EP2833960B1 (en) | 2012-04-05 | 2018-03-07 | The Regents of The University of California | Subcutaneous electrodes for cranial nerve stimulation |
US20140039572A1 (en) | 2012-08-03 | 2014-02-06 | Boston Scientific Neuromodulation Corporation | System and method for treating depression and epilepsy |
CN204147427U (en) | 2012-11-26 | 2015-02-11 | 塞恩克公司 | Wearable electrocutaneous stimulation equipment |
US10220211B2 (en) | 2013-01-22 | 2019-03-05 | Livanova Usa, Inc. | Methods and systems to diagnose depression |
-
2010
- 2010-10-05 JP JP2012533255A patent/JP6035147B2/en active Active
- 2010-10-05 KR KR1020127011816A patent/KR101749605B1/en active IP Right Grant
- 2010-10-05 MX MX2012004050A patent/MX337120B/en active IP Right Grant
- 2010-10-05 KR KR1020127011817A patent/KR101749607B1/en active IP Right Grant
- 2010-10-05 AU AU2010303586A patent/AU2010303586B2/en not_active Ceased
- 2010-10-05 MX MX2012004052A patent/MX2012004052A/en active IP Right Grant
- 2010-10-05 BR BR112012008028A patent/BR112012008028A2/en not_active Application Discontinuation
- 2010-10-05 US US12/898,685 patent/US8958880B2/en active Active
- 2010-10-05 CA CA2776694A patent/CA2776694C/en active Active
- 2010-10-05 EP EP10822565.7A patent/EP2485799A4/en not_active Withdrawn
- 2010-10-05 AU AU2010303588A patent/AU2010303588B2/en active Active
- 2010-10-05 JP JP2012533257A patent/JP5858920B2/en not_active Expired - Fee Related
- 2010-10-05 CA CA2776693A patent/CA2776693C/en active Active
- 2010-10-05 KR KR1020127011818A patent/KR20120101648A/en active Application Filing
- 2010-10-05 BR BR112012008033A patent/BR112012008033A2/en not_active Application Discontinuation
- 2010-10-05 US US12/898,686 patent/US8380315B2/en active Active
- 2010-10-05 EP EP10822560.8A patent/EP2485797A4/en not_active Withdrawn
- 2010-10-05 US US12/898,696 patent/US20110106220A1/en not_active Abandoned
- 2010-10-05 BR BR112012008029A patent/BR112012008029A2/en not_active Application Discontinuation
- 2010-10-05 JP JP2012533258A patent/JP2013506535A/en active Pending
- 2010-10-05 EP EP10822566.5A patent/EP2485800B1/en not_active Not-in-force
- 2010-10-05 BR BR112012008038A patent/BR112012008038A2/en not_active Application Discontinuation
- 2010-10-05 AU AU2010303583A patent/AU2010303583B2/en not_active Ceased
- 2010-10-05 WO PCT/US2010/051544 patent/WO2011044178A1/en active Application Filing
- 2010-10-05 KR KR1020177032427A patent/KR20170127057A/en not_active Application Discontinuation
- 2010-10-05 KR KR1020177032426A patent/KR20170127056A/en not_active Application Discontinuation
- 2010-10-05 CA CA2776696A patent/CA2776696C/en active Active
- 2010-10-05 WO PCT/US2010/051545 patent/WO2011044179A1/en active Application Filing
- 2010-10-05 WO PCT/US2010/051542 patent/WO2011044176A1/en active Application Filing
- 2010-10-05 EP EP10822563.2A patent/EP2485798A4/en not_active Withdrawn
- 2010-10-05 KR KR1020127011819A patent/KR20120101649A/en active Application Filing
- 2010-10-05 CA CA2776697A patent/CA2776697A1/en not_active Abandoned
- 2010-10-05 MX MX2012004053A patent/MX2012004053A/en active IP Right Grant
- 2010-10-05 JP JP2012533256A patent/JP2013506533A/en active Pending
- 2010-10-05 WO PCT/US2010/051539 patent/WO2011044173A1/en active Application Filing
- 2010-10-05 MX MX2012004051A patent/MX2012004051A/en active IP Right Grant
- 2010-10-05 AU AU2010303589A patent/AU2010303589B2/en not_active Ceased
- 2010-10-05 US US12/898,675 patent/US8688220B2/en active Active
-
2013
- 2013-02-15 US US13/769,074 patent/US8700164B2/en active Active
-
2014
- 2014-03-04 US US14/196,990 patent/US20140188200A1/en not_active Abandoned
- 2014-04-14 US US14/252,658 patent/US9238139B2/en active Active
-
2015
- 2015-02-11 US US14/619,898 patent/US9511223B2/en active Active
- 2015-05-26 US US14/721,300 patent/US9504827B2/en active Active
- 2015-07-29 JP JP2015150133A patent/JP6118373B2/en active Active
-
2016
- 2016-01-19 US US15/001,096 patent/US9682236B2/en active Active
- 2016-05-02 US US15/144,499 patent/US20160317814A1/en not_active Abandoned
- 2016-09-20 JP JP2016182754A patent/JP2017000835A/en active Pending
- 2016-10-17 US US15/295,160 patent/US10058704B2/en active Active
- 2016-11-10 US US15/348,097 patent/US10195435B2/en active Active
-
2017
- 2017-05-25 US US15/605,288 patent/US10322283B2/en active Active
-
2018
- 2018-12-05 JP JP2018228425A patent/JP7133453B2/en active Active
-
2019
- 2019-03-04 US US16/291,763 patent/US20190269922A1/en not_active Abandoned
-
2022
- 2022-06-10 JP JP2022094165A patent/JP7541547B2/en active Active
- 2022-06-30 US US17/854,952 patent/US20220331581A1/en not_active Abandoned
- 2022-09-28 US US17/936,334 patent/US20230093826A1/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4233986A (en) * | 1978-07-18 | 1980-11-18 | Agar Ginosar Electronics And Metal Products | Apparatus and method for controlling pain by transcutaneous electrical stimulation (TES) |
US20060064140A1 (en) * | 2001-01-30 | 2006-03-23 | Whitehurst Todd K | Methods and systems for stimulating a trigeminal nerve to treat a psychiatric disorder |
US20060167500A1 (en) * | 2002-08-19 | 2006-07-27 | Bruce Towe | Neurostimulator |
WO2008128215A1 (en) * | 2007-04-13 | 2008-10-23 | Alejandro Covalin | Apparatus and method for the treatment of headache |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9511223B2 (en) | 2009-10-05 | 2016-12-06 | The Regents Of The University Of California | Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders |
US8958880B2 (en) | 2009-10-05 | 2015-02-17 | The Regents Of The University Of California | Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders |
US9238139B2 (en) | 2009-10-05 | 2016-01-19 | The Regents Of The University Of California | Devices, systems and methods for treatment of neuropsychiatric disorders |
US9504827B2 (en) | 2009-10-05 | 2016-11-29 | The Regents Of The University Of California | Systems, devices and methods for the treatment of neurological disorders and conditions |
US10322283B2 (en) | 2009-10-05 | 2019-06-18 | The Regents Of The University Of California | Devices, systems and methods for treatment of neuropsychiatric disorders |
US9682236B2 (en) | 2009-10-05 | 2017-06-20 | The Regents Of The University Of California | Devices, systems and methods for treatment of neuropsychiatric disorders |
US10058704B2 (en) | 2009-10-05 | 2018-08-28 | The Regents Of The University Of California | Systems, devices and methods for the treatment of neurological disorders and conditions |
US10195435B2 (en) | 2009-10-05 | 2019-02-05 | The Regents Of The University Of California | Extracranial implantable devices, systems and methods for the treatment of neuropsychiatric disorders |
US10238862B2 (en) | 2009-10-05 | 2019-03-26 | The Regents Of The University Of California | Extracranial implantable devices, systems and methods for the treatment of medical disorders |
US10639468B2 (en) | 2009-10-05 | 2020-05-05 | The Regents Of The University Of California | Devices, systems and methods for the treatment of medical disorders |
US9364674B2 (en) | 2010-11-30 | 2016-06-14 | Ian A. Cook | Pulse generator for cranial nerve stimulation |
US10016601B2 (en) | 2010-11-30 | 2018-07-10 | The Regents Of The University Of California | Pulse generator for cranial nerve stimulation |
JP2015513980A (en) * | 2012-04-05 | 2015-05-18 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Subcutaneous electrode for cranial nerve stimulation |
US10537703B2 (en) | 2012-11-26 | 2020-01-21 | Thync Global, Inc. | Systems and methods for transdermal electrical stimulation to improve sleep |
US10814131B2 (en) | 2012-11-26 | 2020-10-27 | Thync Global, Inc. | Apparatuses and methods for neuromodulation |
US8880173B2 (en) | 2013-03-12 | 2014-11-04 | Ethicon Endo-Surgery, Inc. | Device for providing transdermal electrical stimulation at an adjustable position on a head |
US10293161B2 (en) | 2013-06-29 | 2019-05-21 | Thync Global, Inc. | Apparatuses and methods for transdermal electrical stimulation of nerves to modify or induce a cognitive state |
US10485971B2 (en) | 2014-10-31 | 2019-11-26 | Avent, Inc. | Non-invasive nerve stimulation system and method |
US10426945B2 (en) | 2015-01-04 | 2019-10-01 | Thync Global, Inc. | Methods and apparatuses for transdermal stimulation of the outer ear |
US11534608B2 (en) | 2015-01-04 | 2022-12-27 | Ist, Llc | Methods and apparatuses for transdermal stimulation of the outer ear |
US10258788B2 (en) | 2015-01-05 | 2019-04-16 | Thync Global, Inc. | Electrodes having surface exclusions |
US10485972B2 (en) | 2015-02-27 | 2019-11-26 | Thync Global, Inc. | Apparatuses and methods for neuromodulation |
US11033731B2 (en) | 2015-05-29 | 2021-06-15 | Thync Global, Inc. | Methods and apparatuses for transdermal electrical stimulation |
US11235148B2 (en) | 2015-12-18 | 2022-02-01 | Thync Global, Inc. | Apparatuses and methods for transdermal electrical stimulation of nerves to modify or induce a cognitive state |
US10646708B2 (en) | 2016-05-20 | 2020-05-12 | Thync Global, Inc. | Transdermal electrical stimulation at the neck |
US11278724B2 (en) | 2018-04-24 | 2022-03-22 | Thync Global, Inc. | Streamlined and pre-set neuromodulators |
US11833352B2 (en) | 2018-04-24 | 2023-12-05 | Thync Global, Inc. | Streamlined and pre-set neuromodulators |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10322283B2 (en) | Devices, systems and methods for treatment of neuropsychiatric disorders | |
AU2015264876B2 (en) | Devices, Systems and Methods for Treatment of Neuropsychiatric Disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10822563 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2776694 Country of ref document: CA Ref document number: MX/A/2012/004050 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012533256 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010303586 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010822563 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 20127011817 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2010303586 Country of ref document: AU Date of ref document: 20101005 Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112012008028 Country of ref document: BR |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 112012008028 Country of ref document: BR Kind code of ref document: A2 Effective date: 20120405 |